Key points from article :
Jupiter Neurosciences has partnered with Aquanova AG to create a series of consumer products targeting longevity and healthspan, based on its patented resveratrol-based platform, JOTROL™. The collaboration aims to combine Jupiter’s clinical expertise with Aquanova’s formulation technology to bring science-backed, effective products to the growing market of ageing and health. These products, under the "Beauty from Within" concept, will focus on promoting overall health and longevity, with the first three set to launch in Q3 2025.
JOTROL™, a resveratrol formulation designed for better bioavailability, has shown promising results in preclinical and clinical trials, particularly in treating neurodegenerative diseases like Alzheimer’s and Parkinson’s. Through this partnership, Jupiter aims to leverage Aquanova's NovaSOL® technology to overcome resveratrol's bioavailability challenges, ensuring its effective absorption without gastrointestinal side effects.
This initiative also includes the establishment of a new subsidiary that will market the consumer products, providing an additional revenue stream to support Jupiter's ongoing pharmaceutical trials. The move reflects a growing demand for scientifically validated solutions in ageing and healthspan, with Jupiter’s leadership emphasizing the potential of this venture to deliver life-changing benefits for patients and consumers alike.
